Heidelberg Pharma AG (LON:0QW5)

Heidelberg Pharma AG Statistics

Total Valuation

LON:0QW5 has a market cap or net worth of GBP 180.82 million. The enterprise value is 152.19 million.

Market Cap	180.82M
Enterprise Value	152.19M

Important Dates

The last earnings date was Thursday, July 10, 2025.

Earnings Date	Jul 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	46.60M
Shares Outstanding	n/a
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+4.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	9.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	51.33
PB Ratio	11.60
P/TBV Ratio	22.19
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.75
EV / Sales	42.10
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.64

Financial Position

The company has a current ratio of 7.74, with a Debt / Equity ratio of 0.01.

Current Ratio	7.74
Quick Ratio	5.64
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.00
Interest Coverage	-5,400.22

Financial Efficiency

Return on equity (ROE) is -78.11% and return on invested capital (ROIC) is -56.21%.

Return on Equity (ROE)	-78.11%
Return on Assets (ROA)	-25.08%
Return on Invested Capital (ROIC)	-56.21%
Return on Capital Employed (ROCE)	-48.08%
Revenue Per Employee	31,734
Profits Per Employee	-176,810
Employee Count	105
Asset Turnover	0.06
Inventory Turnover	0.04

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +82.64% in the last 52 weeks. The beta is -0.28, so LON:0QW5's price volatility has been lower than the market average.

Beta (5Y)	-0.28
52-Week Price Change	+82.64%
50-Day Moving Average	3.97
200-Day Moving Average	3.33
Relative Strength Index (RSI)	49.54
Average Volume (20 Days)	248

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:0QW5 had revenue of GBP 3.52 million and -19.63 million in losses. Loss per share was -0.42.

Revenue	3.52M
Gross Profit	3.08M
Operating Income	-22.71M
Pretax Income	-19.63M
Net Income	-19.63M
EBITDA	-22.09M
EBIT	-22.71M
Loss Per Share	-0.42

Balance Sheet

The company has 28.00 million in cash and 102,918 in debt, giving a net cash position of 27.90 million.

Cash & Cash Equivalents	28.00M
Total Debt	102,918
Net Cash	27.90M
Net Cash Per Share	n/a
Equity (Book Value)	15.59M
Book Value Per Share	0.33
Working Capital	36.08M

Cash Flow

In the last 12 months, operating cash flow was -22.55 million and capital expenditures -379,465, giving a free cash flow of -22.93 million.

Operating Cash Flow	-22.55M
Capital Expenditures	-379,465
Free Cash Flow	-22.93M
FCF Per Share	n/a

Margins

Gross Margin	87.55%
Operating Margin	-644.66%
Pretax Margin	-557.16%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0QW5 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.01%
Shareholder Yield	n/a
Earnings Yield	-10.85%
FCF Yield	-12.68%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 7, 2017. It was a forward split with a ratio of 1.0464082038.

Last Split Date	Nov 7, 2017
Split Type	Forward
Split Ratio	1.0464082038

Scores

LON:0QW5 has an Altman Z-Score of -6.59 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.59
Piotroski F-Score	2